Cargando…
Plasmacytoid Dendritic Cells as Cell-Based Therapeutics: A Novel Immunotherapy to Treat Human Immunodeficiency Virus Infection?
Dendritic cells (DCs) play a critical role in mediating innate and adaptive immune responses. Since their discovery in the late 1970's, DCs have been recognized as the most potent antigen-presenting cells (APCs). DCs have a superior capacity for acquiring, processing, and presenting antigens to...
Autores principales: | van der Sluis, Renée M., Egedal, Johanne H., Jakobsen, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264089/ https://www.ncbi.nlm.nih.gov/pubmed/32528903 http://dx.doi.org/10.3389/fcimb.2020.00249 |
Ejemplares similares
-
Cell-Extrinsic Priming Increases Permissiveness of CD4+ T Cells to Human Immunodeficiency Virus Infection by Increasing C–C Chemokine Receptor Type 5 Co-receptor Expression and Cellular Activation Status
por: Pedersen, Jesper G., et al.
Publicado: (2021) -
Plasmacytoid dendritic cells during COVID-19: Ally or adversary?
por: Van der Sluis, Renée Marije, et al.
Publicado: (2022) -
Editorial: Exploring Novel Approaches to Eliminate HIV Reservoirs to Achieve a Cure for HIV
por: van der Sluis, Renée M., et al.
Publicado: (2021) -
Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy
por: Hernández, Sabina Sánchez, et al.
Publicado: (2022) -
Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity
por: Mi, Youjun, et al.
Publicado: (2022)